Apogee Therapeutics Inc (NASDAQ: APGE): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

APGE belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Apogee Therapeutics Inc is $2.59B. A total of 0.73 million shares were traded on the day, compared to an average of 720.56K shares.

In the most recent transaction, Dambkowski Carl sold 2,725 shares of APGE for 36.96 per share on Jun 04 ’25. After the transaction, the Chief Medical Officer now owns 241,723 company shares. In a previous transaction on May 07 ’25, Dambkowski Carl sold 2,725 shares at 35.75 per share. APGE shares that Chief Medical Officer owns now total 244,448.

Among the insiders who sold shares, Dambkowski Carl disposed of 3,860 shares on Apr 02 ’25 at a per-share price of $36.22. This resulted in the Chief Medical Officer holding 247,173 shares of APGE after the transaction. In another insider transaction, CARL DAMBKOWSKI bought 9,310 shares at $35.61 per share on Apr 02 ’25.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, APGE has a high of $63.50 and a low of $26.20.

As of this writing, APGE has an earnings estimate of -$1.03 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.96 per share and a lower estimate of -$1.11.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APGE is Buy with a score of 5.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.